Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 13, 2020
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2AMatteo Campioni, Paulette Legendre, Cécile Loubiere, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applicationsIvan Peyron, Claire Kizlik-Masson, Marie-Daniéla Dubois, et al.
Blood|August 2, 2018
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formationVincent Muczynski, Caterina Casari, François Moreau, et al.
Haematologica|January 13, 2018
Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factorNikolett Wohner, Vincent Muczynski, Amel Mohamadi, et al.
Haematologica|May 14, 2026
Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patientsSénadé Atsou, Alexia Rinsant, Caterina Casari, et al.
Blood|May 6, 2020
A hemophilia A mouse model for the in vivo assessment of emicizumab functionStephen Ferrière, Ivan Peyron, Olivier D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generationCharlotte Kawecki, Karen Aymonnier, Stephen Ferrière, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factorNathalie Saint-Lu, Beatrijs D Oortwijn, Julie N Pegon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patientsBharath Wootla, Antonino Nicoletti, Natacha Patey, et al.
Haematologica|December 7, 2023
Differences in venous clot structures between hemophilic mice treated with emicizumab <i>versus</i> factor VIII or factor VIIIFcThibaud Sefiane, Hortense Maynadié, Carmen Escurola Ettingshausen, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|October 13, 2020
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2AMatteo Campioni, Paulette Legendre, Cécile Loubiere, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applicationsIvan Peyron, Claire Kizlik-Masson, Marie-Daniéla Dubois, et al.
Blood|August 2, 2018
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formationVincent Muczynski, Caterina Casari, François Moreau, et al.
Haematologica|January 13, 2018
Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factorNikolett Wohner, Vincent Muczynski, Amel Mohamadi, et al.
Haematologica|May 14, 2026
Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patientsSénadé Atsou, Alexia Rinsant, Caterina Casari, et al.
Blood|May 6, 2020
A hemophilia A mouse model for the in vivo assessment of emicizumab functionStephen Ferrière, Ivan Peyron, Olivier D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generationCharlotte Kawecki, Karen Aymonnier, Stephen Ferrière, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2012
Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factorNathalie Saint-Lu, Beatrijs D Oortwijn, Julie N Pegon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patientsBharath Wootla, Antonino Nicoletti, Natacha Patey, et al.
Haematologica|December 7, 2023
Differences in venous clot structures between hemophilic mice treated with emicizumab <i>versus</i> factor VIII or factor VIIIFcThibaud Sefiane, Hortense Maynadié, Carmen Escurola Ettingshausen, et al.
Pageof 15